explore -WSS

explore

author：comprehensive 2025-09-30 17:44:01 - browse：95

A screen at the New York Stock Exchange last November. Michael M. Santiago/Getty Images

Pfizer spent more than four hours Thursday laying out its oncology program to investors. But the company also spent some time talking about the effects of the Inflation Reduction Act on its pipeline.

The drug giant, which is facing investor dissatisfaction after a year in which its stock dropped 44%, said it would be focusing on drugs that are based on proteins, not small molecule pills as it has traditionally developed. (Pfizer’s current best-seller in oncology, Ibrance for breast cancer, is a small molecule pill.) It said the mix of small molecule drugs in its cancer portfolio will drop from 94% last year to 35% in 2030.

That matters because small molecules are more vulnerable to generic competition and the Medicare price negotiation introduced by the IRA. Suneet Varma, the commercial president of Pfizer’s oncology unit, said “this planned shift to biologics is expected to support the accelerated growth in both the top and bottom line,” referring to the revenue and profit lines of a balance sheet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Yancopoulos of Regeneron works to expand Dupixent success

WSS

Manchin plays down potential 3rd

Mirador, a new biotech startup, launches with $400 million

BridgeBio heart drug succeeds in pivotal study

Texas board proposes rules on abortion law emergency exemption

Readout Newsletter: Illumina, CRISPR, Regeneron

Diabetes management: Digital health tools fall short, study says

Wikipedia

explore

focus

Supreme Court strikes down use of affirmative action

BridgeBio heart drug succeeds in pivotal study

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: Illumina, CRISPR, Regeneron

United colonoscopy coverage change 'may cost lives,' doctors say

Medicare Advantage insurers pressure Biden for bigger payments

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

ER docs worry over extreme heat as a 'mass casualty event'

Jerome Adams on the need for new antivirals for Covid

Johnson & Johnson sues to stop Medicare negotiation

knowledge

Manchin plays down potential 3rd

6 surprising facts about sugar

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Medicare Advantage insurers pressure Biden for bigger payments

Steward Health Care expansion into Malta flopped

This gene therapy has record $4.25 million price. It's saved children.

entertainment

leisure time

entertainment

knowledge